Follow-up of Treated Eating Disordered Males and Gender-specific Risk Factors – A Prospective, Controlled Study

• Conditions: F50.0; F50.1; F50.2; F50.3; F50.9; Anorexia nervosa; Atypical anorexia nervosa; Bulimia nervosa; Atypical bulimia nervosa; Eating disorder, unspecified

• Registration Number: DRKS00011127
• Lead Sponsor: Klinik und Poliklinik für Psychiatrie und PsychotherapieLudwig-Maximilians-Universität MünchenForschungsbereich Epidemiologie und Evaluation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09-30
• Study Completion: 2018-10-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 334

Inclusion Criteria

Informed consent, Inpatient treatment for Anorexia nervosa, Bulimia nervosa oder Binge Eating Disorder in Schön Klinik Roseneck hospital.
Analoguous data from female inpatients collected in the same way as for males will be used.

Exclusion Criteria

Mental or physical illness excluding appropriate participation in the study

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Admission, discharge, follow-up: Body weight, eating disorder-specific and general psychopathology. Follow-up:: standardized mortality, diagnostic outcome (eating disorder diagnosis according to DSM-IV, DSM-5 and ICD-10)

Secondary Outcome Measures

Name	Time	Method
Description of gender-specific course and outcome, and assessment of risk factors. Data from clinical expert ratings (SIAB-EX, PSR) and self-rating questionnaires (SIAB-S, EDI, BSI, Munich ED-Quest, DMS, CET, CET) will be collected. Main assessment time point are 1. admission to inpatient treatment, 2. discharge from inpatient treatment, 3. follow-up.